Moneycontrol
HomeNewsBusinessMoneycontrol ResearchHow price-to-book value as a valuation tool could turn into a trap
Trending Topics

How price-to-book value as a valuation tool could turn into a trap

Checklist when price to book value becomes a trap: - When the stated value of assets in the books is higher than their realisable value - When a company’s balance sheet contains too many intangibles - When the company has huge contingent liabilities - When a large part of the liability is shifted to the future

April 15, 2019 / 17:56 IST
Story continues below Advertisement

The last few months have been a bargain hunters’ market with investors picking up stressed stocks. But many of these bargains could be traps. In a two part series (Part-2), we dig into the pitfalls of investing in stocks considered cheap based on the price-to-book value metric.

Checklist when price to book value becomes a trap: - When the stated value of assets in the books is higher than their realisable value
- When a company’s balance sheet contains too many intangibles
- When the company has huge contingent liabilities
- When a large part of the liability is shifted to the future

During times of stress in the market, investors hunt for bargains and one valuation yardstick used by most of them is price-to-book value. However, there are many pitfalls of using this measure, often ignored by investors.

Story continues below Advertisement

We detail seven such ways in which P/B value as a tool of valuation can turn out to be a trap for bargain hunters. The first four are listed below, the rest will be discussed in Part 2.

Case 1: When the stated value of assets in the books is higher than their realisable value In the last few years, many companies including Tata Steel, GMR Infrastructure and others took huge write-offs, knocking down the value of assets sitting in their books.

For example, in the September quarter of FY19, Hindustan Construction Company (HCC) reported a net loss of Rs 1,525 crore as against a profit of Rs 11 crore in the year ago quarter as the company wrote off its entire investments in Lavasa -- a subsidiary of HCC, which has been referred to the bankruptcy court. While HCC has a negative net worth and book value, had it happened to any healthy company the book value per share would have dropped significantly.